Loading
Latest filing published 27 Apr 2026 for Mustang Bio, INC., €12.
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Manuel Litchman MD is a declared insider of Mustang Bio, Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 30 filings cover trades dated from 20 November 2018 to 24 April 2026.
The open-market side counts 14 purchases for €2.0M alongside 2 sales for €34k. On balance, insiders were net buyers of €2.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 14 share grants.
Half of the purchases are above €75k and half below. 7 out of 13 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 27 April 2026 with a share grant (€12) in Mustang Bio, Inc. The last purchase on record was published on 3 April 2023, which is 1,300 days ago. The median gap between a trade and its publication by SEC (Form 4) is 23 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations